Preeclampsia sFlt-1 filtering breakthrough treatment
Key Questions
What is the sFlt-1 filtering treatment for preeclampsia?
It filters the sFlt-1 protein from blood in early preeclampsia cases, extending pregnancies by a median of 10 days in a 16-woman study. It also caused a slight blood pressure drop.
How common is preeclampsia and what are the benefits of this treatment?
Preeclampsia affects 3-8% of pregnancies; this non-delivery option could avert preterm risks. Larger trials are needed for confirmation.
What outcomes were seen in the sFlt-1 study?
The treatment prolonged gestation by 10 days median, offering tailored care potential. It shows promise but requires further research.
Early preeclampsia cases treated by filtering sFlt-1 protein from blood extended pregnancies median 10 days (16-woman study), slight BP drop; 3-8% prevalence, potential non-delivery option to avert preterm risks. Needs larger trials but promising for tailored care.
Sources (2)
Updated Apr 30, 2026